Aerolase
777 Old Saw Mill River Road
Tarrytown
New York
10591
United States
Tel: 877-379-2435 or 914-345-8300
Fax: 914-345-8303
Website: http://aerolase.com/
Email: information@aerolase.com
About Aerolase
Aerolase develops, manufacturers and markets new advanced laser technologies for dermatology and aesthetic applications. Driven by clinical research, our laser engineering team exclusively produces medical laser solutions that deliver a superior combination of efficacy and safety in therapeutic treatment.YEAR FOUNDED:
1996
LEADERSHIP:
Founder and CEO: Pavel Efremkin
PRODUCTS:
All Products
FOLLOW AEROLASE:
Tweets by Aerolase
6 articles about Aerolase
-
Aerolase Further Extends Treatment Range for Its Universal Skin Laser Technology
3/25/2022
Building on the strong 2021 year in which Aerolase revenues grew 120%, Aerolase is pleased to announce a new major growth initiative to further enhance the company's offering for dermatologists not concentrated on aesthetics.
-
Two Independent Expert Studies Show Novel Advantages of Unique Aerolase Laser in Treating Acne, One of the Most Troublesome Dermatological Disorders
2/2/2021
Among all skin conditions, acne is one of the most widespread and challenging to treat, and troubling for the patient.
-
Aerolase Named to Inc. 5000, Further Enhances Leadership Team, Regains Sales Growth after COVID Pause
8/17/2020
Aerolase Inc. is proud to announce its debut on the iconic Inc. 5000 list of America's fastest-growing private companies as measured by revenues. In the just-released list for this year, it is solidly in the top half, at #2020 in the rankings.
-
Aerolase Corp. Appoints Dermatology Industry Corporate Executive Didier Leclercq to Leadership Team
6/29/2020
Aerolase Corp. has named Didier Leclercq , most recently Managing Director of the SHIELD innovation center of Nestlé Skin Health/Galderma, in New York City , as its Vice President of Global Market Development. He will be based in Aerolase headquarters in Tarrytown .
-
Cardiovascular Systems, Inc. and Aerolase Corp. Sign Collaborative Agreement for Laser Atherectomy Technology
7/31/2018
Cardiovascular Systems, Inc. today announced that it has signed an agreement with Aerolase Corp. to co-develop a new laser atherectomy device for physicians to use in more effectively treating multiple forms of arterial disease.
-
Aerolase Hires Prominent Laser Sales Executive As VP Sales To Accelerate Expansion
10/13/2016